Tag
More medication options and updated research about medication effectiveness has led to an update in AS treatment guidelines from the American College of Rheumatology.
Taltz inhibits an immune system protein called IL-17 that can lead to inflammation.
This adds to what we know about environmental risk factors for autoimmune-related diseases.
The inflammatory arthritis ankylosing spondylitis can impact your entire body. Learn more about common ankylosing spondylitis comorbidities and how to prevent and manage them.
Knowing the factors that contribute to AS risk can help you watch out for them and possibly accelerate your diagnosis and treatment.
Almost half of patients who start a TNF inhibitor biologic are not on the same treatment a few years later.
Here’s what you need to know about having a healthy pregnancy with PsA and AS.
Depression is very common among people with AS. Here’s what patients and doctors need to know about it.
A new study found that AS patients on anti-TNF drugs had fewer doctor and ER visits and didn’t skip work as often.
Learn more about what can happen to your chances of being in remission when you stop taking a biologic drug.
By 
By 
